Literature DB >> 10213688

Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator.

Y H Kim1, J H Park, S H Hong, J Y Koh.   

Abstract

Human recombinant tissue plasminogen activator (tPA) may benefit ischemic stroke patients by dissolving clots. However, independent of thrombolysis, tPA may also have deleterious effects on neurons by promoting excitotoxicity. Zinc neurotoxicity has been shown to be an additional key mechanism in brain injuries. Hence, if tPA affects zinc neurotoxicity, this may provide additional insights into its effect on neuronal death. Independent of its proteolytic action, tPA markedly attenuated zinc-induced cell death in cortical culture, and, when injected into cerebrospinal fluid, also reduced kainate seizure-induced hippocampal neuronal death in adult rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213688     DOI: 10.1126/science.284.5414.647

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  53 in total

1.  Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets.

Authors:  Diansan Su; John Riley; William M Armstead; Renyu Liu
Journal:  Anesth Analg       Date:  2011-11-10       Impact factor: 5.108

2.  Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Authors:  M Zhuo; D M Holtzman; Y Li; H Osaka; J DeMaro; M Jacquin; G Bu
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Brain Res       Date:  2010-12-20       Impact factor: 3.252

Review 4.  Role of thrombolytic agents in cardiac arrest.

Authors:  D K Pedley; W G Morrison
Journal:  Emerg Med J       Date:  2006-10       Impact factor: 2.740

5.  Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.

Authors:  E Lemarchand; E Maubert; B Haelewyn; C Ali; M Rubio; D Vivien
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

6.  Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.

Authors:  Ramiro Echeverry; Jialing Wu; Woldeab B Haile; Johanna Guzman; Manuel Yepes
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

7.  Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis.

Authors:  C T Sheline; M M Behrens; D W Choi
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

8.  Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.

Authors:  Michal Kremen; Ranjini Krishnan; Isaac Emery; Jie Hong Hu; Katherine I Slezicki; Alyssa Wu; Kun Qian; Liang Du; Abigail Plawman; April Stempien-Otero; David A Dichek
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

Review 9.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

10.  Endogenous zinc in neurological diseases.

Authors:  Jae-Yong Koh
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.